Integration of Neurocognitive Biomarkers Into a Neuro-Oncology Clinic

Recruiting now

Conditions studied: Neurocognitive Disorders

In brief

This is prospective observational registry study that will assess 1) if the neurocognitive function app (Brainlab Cognition) can be used in a widespread neuro-oncology clinic setting and 2) if patient reported quality of life parameters can be obtained electronically and integrated into clinic.

Key facts

Study ID

NCT05504681

Run by

Baptist Health South Florida

People needed

200

Starts

2021-11-30

Expected to finish

2032-04-01

Last updated by the study team

2026-05-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• All adult (18+) patients with central nervous system (CNS) tumors, both primary brain malignancies and brain metastases, treated with radiotherapy (partial brain, stereotactic radiosurgery, stereotactic fractionated radiotherapy, or whole-brain radiotherapy), surgery, and/or antineoplastic therapy and followed thereafter at Miami Cancer Institute (MCI)
• Life expectancy ≥ 6 months
• Willingness to participate in ongoing registration study

You may not qualify if…

• Patients receiving radiotherapy to the brain for functional disease (arteriovenous malformations, trigeminal neuralgia, essential tremors, etc.)
• Pediatric patients (<18 years old), pregnant women, and prisoners.

Where it is running

• Miami Cancer Institute — Miami, Florida, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.